XJPX
3034
Market cap557mUSD
Oct 09, Last price
2,348.00JPY
1D
0.17%
1Q
15.04%
Jan 2017
67.71%
IPO
717.41%
Name
Qol Holdings Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Tokyo, Japan, Qol Holdings Co., Ltd., established in 1992, operates a diverse portfolio of businesses, primarily focusing on dispensing pharmacies and business process outsourcing (BPO) within the healthcare sector. The company establishes its dispensing pharmacies through tailored, trust-based relationships with individual medical institutions. Beyond its pharmacy operations, Qol Holdings provides extensive BPO services, including conducting sales and marketing research for pharmaceutical companies. It also specializes in dispatching temporary staff across various medical professions, such as pharmacists, nurses, registered sellers, and dietitians. Additionally, the company offers comprehensive support for clinical trials involving both pharmaceuticals and food products. This support encompasses a broad spectrum of services, from assisting with trial execution planning and monitoring to providing secretariat support, statistical analysis, and facilitating the presentation of conference papers, often through the dispatch of skilled managers and technicians. The company further extends its offerings to include publishing-related services. Originally named Qol Co., Ltd., the company adopted its current name, Qol Holdings Co., Ltd., in October 2018.
Key people
Masaru Nakamura
Honorary Chairman · since 2024
Takashi Nakamura
President, Representative Director · since 2021
Shinobu Karasawa
Managing Director, President of Subsidiary · since 2025
Yuji Suzuki
Director of Pharmacy Business Promotion Function, Director · since 2025
Yutaka Togashi
Director of Human Resource Planning, Director · since 2025
Kiyonobu Fukumitsu
Managing Director, Representative Director · since 2024
Kei Imai
Director of Business Planning, Director · since 2024
Kazuo Ishii
Director · since 2023
Takayoshi Ishii
Senior Managing Director, Representative Director · since 2023
Independent Director · since 2015
Motoyuki Miyazaki
Independent Director · since 2021
Yasutoshi Mori
Independent Director · since 2023
Yukiharu Yamamoto
Independent Director · since 2019
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||